An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3) - PubMed (original) (raw)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)

S R Burrows et al. J Exp Med. 1990.

Abstract

Epstein-Barr virus (EBV)-specific CTL clones were isolated that recognized A-type EBV transformants but not B-type transformants. These A-type-specific CTL clones (HLA B8 restricted) were used to screen peptides derived from the EBV nuclear antigens (EBNAs) 2, 3, 4, and 6 as potential CTL epitopes. Of the 76 peptides screened, one sequence from EBNA 3 (residues 329-353) was recognized by A-type-specific CTL clones after absorption onto target cells (either autologous B-type transformants or PHA blasts). This report is the first description of an EBV target epitope recognized by specific CTL clones.

PubMed Disclaimer

Similar articles

• Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
  Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ. Khanna R, et al. J Exp Med. 1992 Jul 1;176(1):169-76. doi: 10.1084/jem.176.1.169. J Exp Med. 1992. PMID: 1377222 Free PMC article.
• Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
  Misko IS, Schmidt C, Moss DJ, Burrows SR, Sculley TB. Misko IS, et al. J Gen Virol. 1991 Feb;72 ( Pt 2):405-9. doi: 10.1099/0022-1317-72-2-405. J Gen Virol. 1991. PMID: 1704413
• Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
  Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E, et al. Murray RJ, et al. Proc Natl Acad Sci U S A. 1990 Apr;87(8):2906-10. doi: 10.1073/pnas.87.8.2906. Proc Natl Acad Sci U S A. 1990. PMID: 2158098 Free PMC article.
• Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis.
  Moss DJ, Misko IS, Sculley TB, Apolloni A, Khanna R, Burrows SR. Moss DJ, et al. Springer Semin Immunopathol. 1991;13(2):147-56. doi: 10.1007/BF00201465. Springer Semin Immunopathol. 1991. PMID: 1724100 Review. No abstract available.
• T cell recognition of Epstein-Barr virus associated lymphomas.
  Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG. Rickinson AB, et al. Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review.

Cited by

• Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
  Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ. Khanna R, et al. J Exp Med. 1992 Jul 1;176(1):169-76. doi: 10.1084/jem.176.1.169. J Exp Med. 1992. PMID: 1377222 Free PMC article.
• Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.
  Yao QY, Tierney RJ, Croom-Carter D, Dukers D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB. Yao QY, et al. J Virol. 1996 Aug;70(8):4884-94. doi: 10.1128/JVI.70.8.4884-4894.1996. J Virol. 1996. PMID: 8763991 Free PMC article.
• Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients.
  Lakhdar M, Thameur H, Maalej M, Ben Ayed F, Ladgham A. Lakhdar M, et al. Cancer Immunol Immunother. 1993 Jul;37(2):131-9. doi: 10.1007/BF01517046. Cancer Immunol Immunother. 1993. PMID: 8391392 Free PMC article.
• Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B.
  Martin LK, Hollaus A, Stahuber A, Hübener C, Fraccaroli A, Tischer J, Schub A, Moosmann A. Martin LK, et al. PLoS Pathog. 2018 Apr 26;14(4):e1006991. doi: 10.1371/journal.ppat.1006991. eCollection 2018 Apr. PLoS Pathog. 2018. PMID: 29698478 Free PMC article.
• Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.
  Steven NM, Leese AM, Annels NE, Lee SP, Rickinson AB. Steven NM, et al. J Exp Med. 1996 Nov 1;184(5):1801-13. doi: 10.1084/jem.184.5.1801. J Exp Med. 1996. PMID: 8920868 Free PMC article.

References

1. 1. J Exp Med. 1988 Jun 1;167(6):1811-24 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4567-71 - PubMed
3. 1. J Gen Virol. 1987 Nov;68 ( Pt 11):2853-62 - PubMed
4. 1. Virology. 1989 Aug;171(2):401-8 - PubMed
5. 1. J Virol. 1989 Mar;63(3):1031-9 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Immune Epitope Database and Analysis Resource

• Research Materials

  • NCI CPTC Antibody Characterization Program